1 / 5

Non-Communicable Diseases (NCDs) Sandeep P. Kishore, Ph.D.

Non-Communicable Diseases (NCDs) Sandeep P. Kishore, Ph.D. Young Professionals Chronic Disease Network Universities Allied for Essential Medicines. The Global Burden of Disease (Mortality). Disease Deaths (x 10^6) % of total Ischemic heart disease 7.2 12.2

dawson
Download Presentation

Non-Communicable Diseases (NCDs) Sandeep P. Kishore, Ph.D.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Non-Communicable Diseases (NCDs) Sandeep P. Kishore, Ph.D. Young Professionals Chronic Disease Network Universities Allied for Essential Medicines

  2. The Global Burden of Disease (Mortality) Disease Deaths (x 10^6) % of total Ischemic heart disease 7.2 12.2 Cerebrovascular disease 5.7 9.7 Lower respiratory infections 4.2 7.1 COPD 3.0 5.1 Diarrheal Diseases 2.2 3.7 HIV/AIDS 2.0 3.5 Tuberculosis 1.5 2.5 Trachea, bronchus and lung cancers 1.3 2.3 Road Traffic Accidents 1.3 2.2 Premature birth/low birth weight 1.2 2.0 … Malaria 0.9 1.5 15. Birth trauma 0.9 1.5 16. Self-inflicted injuries 0.8 1.4

  3. Burden of Disease • Tobacco (1 in 10 deaths, women,youth) • Poor diets (high-fat, high-salt, sugary) • 3. Inadequate physical activity • 4. Harmful use of alcohol $7536 $30 $19

  4. 4/2011– WHO Global Forum on NCDs (IFPMA chairs A2M session; civil society groups are pharma-funded; affirm IP non-issue…)) 8/2011 – UN political draft declaration negotiations stall (trade issues) TRIPS flex/Doha/IPR @ center. Bullying by EU/USA. 10/2010 – Modalities Resolution for NCD HLM @ UNGA 9/2011 – HLM @ UNGA. References to Doha excised. HPV/HBV vaccines called for. First youth rally on NCDs @ UN. 1/2012 – WHO EB (Targets/commitments) [Access Indicator]; for global monitoring system finalized by WHA 5/2012 6/2012 – Rio+20 Sustainable Development (MDGs)/ UNDP 12/2012 – Proposals for a global partnership (e.g. Stop NCDs); [COI] 9/2014 – Review of UN NCD HLM

  5. Short-term: 1. Focus on influencing the 2012 WHO targets/commitments process. Formulate and lobby for time-bound, numerical A2M indicator. 2. Drug-specific: heart disease (fixed dose combination; polypill); cancer (HPV; HBV vaccines; herceptin, imatinib); diabetes (insulin); asthma (patented inhaler technology). CANCER AS PRIORITY. 3. Feed outrage at surgical removal of Doha Declaration from NCD political declaration into statement / press release from this meeting Long-term: 1. Aggressively call out/resist pharmaceutical COI in public sector policy-making / civil society actors and via nodal patient advocacy groups. 2. NCDs framed in human rights context (e.g. youth/students) 3. Global mapping re: price/generic manufacturers/tech transfer OSI Scoping paper on disease-/ field-specific strategies 4. Beyond IP: Procurement/Stop Stock Out campaigns for off patent meds (e.g.aspirin, beta blockers)

More Related